Persons residing in long-term care homes for Alzheimer Disease

Phase-Based Progress Estimates
Northbrook Inn, Northbrook, IL
Alzheimer Disease+2 More
A novel digital health device - Device
Any Age
All Sexes
What conditions do you have?

Study Summary

This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

Eligible Conditions

  • Alzheimer Disease
  • Dementia
  • Neurodegenerative Diseases

Treatment Effectiveness

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: 8 weeks

8 weeks
Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- severe)
Approaches to Dementia Questionnaire (ADQ)
Dementia Quality of Life - Care Home (DemQol-CH)
Sense of Competence in Dementia Care Staff (SCIDS) scale
The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The minimum and maximum values are A higher score means a better or worse outcome.

Trial Safety

Trial Design

1 Treatment Group

Persons residing in long-term care homes
1 of 1
Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Persons residing in long-term care homes · No Placebo Group · N/A

Persons residing in long-term care homes
Experimental Group · 1 Intervention: A novel digital health device · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks

Trial Background

mandy, CEO
Principal Investigator
Mentia DTx
Closest Location: Northbrook Inn · Northbrook, IL
N/AFirst Recorded Clinical Trial
1 TrialsResearching Alzheimer Disease
0 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Can sit comfortably for at least 15 minutes in a chair/wheelchair at a table or propped up in bed or princess chair with a tray table.
You have good vision.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.